Synapsoft logo
AI Insights from Disclosures
Searching...
ToolGen Incorporated 199800
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
ToolGen Incorporated engages in a single segment covering gene-editing research and development, patent monetization based on gene-editing platform technology, and the development of therapeutics and plant/animal products, as of the date of this report. The company aims to use gene-editing (gene scissors) technology to give humankind a disease-free, healthy life and to create an abundant life through the breeding of plants and animals. Driven by the development of CRISPR/Cas9, gene-editing technology is expected to bring innovation to the development of treatments for genetic diseases and cancer, as well as to high-value-added plant and animal variety improvement that overcomes the limits of genetic resources.
Representative Director Yu Jongsang
Founded October 8, 1999
Corporation Type KOSDAQ
Industry Classification Research and experimental development on natural sciences and engineering
Corporate number 11011-1785827
Business number 108-81-18555
Phone Number 02-3660-1334
Fax Number 02-873-8169
Website toolgen.com
Company Address 172 Magokjungang-ro, Gangseo-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant